ALKBH3 and ocular melanoma: Consistently, the stable knockdown of SP100A resulted in a compromised expression of PML expression in both wild-type (Figure 6F, lanes 1 and 3) and ALKBH3-deficient ocular melanoma cells (Figure 6F, lanes 2 and 4).